Human immune responses and potential for vaccine assessment in humanized mice

Current Opinion in Immunology

Volumn 25, Issue 3, 2013, Pages 403-409

  Akkina, Ramesh ^a  

^a Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN M; TETANUS TOXOID; VACCINE;

B LYMPHOCYTE; CELLULAR IMMUNITY; DENDRITIC CELL; DENGUE; EPSTEIN BARR VIRUS INFECTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNIZATION; IMMUNOCOMPETENT CELL; IMMUNOGLOBULIN PRODUCTION; IMMUNOPROPHYLAXIS; INNATE IMMUNITY; LIVER TRANSPLANTATION; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; REVIEW; T LYMPHOCYTE; TETANUS; THYMUS TRANSPLANTATION;

ANIMALS; HLA ANTIGENS; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC DEFICIENCY SYNDROMES; MICE; VACCINES;

EID: 84879200744     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2013.03.009     Document Type: Review

References (59)

1. Davis M.M. A prescription for human immunology. Immunity 2008, 29:835-838.
2. Akkina R. New generation humanized mice for virus research: comparative aspects and future prospects. Virology 2013, 435:14-28.
3. McCune J.M. Development and applications of the SCID-hu mouse model. Semin Immunol 1996, 8:187-196.
4. Mosier D.E. Evaluation of protective immunity to HIV-1 in human PBL-SCID mice. Antibiot Chemother 1996, 48:125-130.
5. Shultz L.D., Ishikawa F., Greiner D.L. Humanized mice in translational biomedical research. Nat Rev Immunol 2007, 7:118-130.
6. Ito R., et al. Current advances in humanized mouse models. Cell Mol Immunol 2012, 9:208-214.
7. Rongvaux A., et al. Human hemato-lymphoid system mice: current use and future potential for medicine. Annu Rev Immunol 2013.
8. Mosier D.E. Human xenograft models for virus infection. Virology 2000, 271:215-219.
9. -/- (RAG-hu) mice. Virology 2008, 373:342-351.
10. Veselinovic M., et al. Topical gel formulation of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 confers protection against HIV-1 vaginal challenge in a humanized mouse model. Virology 2012, 432:505-510.
11. Hur E.M., et al. Inhibitory effect of HIV-specific neutralizing IgA on mucosal transmission of HIV in humanized mice. Blood 2012, 120:4571-4582.
12. + cell transplantation. Blood 2006, 108:487-492.
13. Melkus M.W., et al. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med 2006, 12:1316-1322.
14. Denton P.W., Garcia J.V. Mucosal HIV-1 transmission and prevention strategies in BLT humanized mice. Trends Microbiol 2012, 20:268-274.
15. Meuleman P., Leroux-Roels G. The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV. Antiviral Res 2008, 80:231-238.
16. Zhou X.L., et al. Humanized murine model for HBV and HCV using human induced pluripotent stem cells. Arch Pharmacol Res 2012, 35:261-269.
17. Washburn M.L., et al. A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. Gastroenterology 2011, 140:1334-1344.
18. Chang H., et al. Human B-cell ontogeny in humanized NOD/SCID gammac(null) mice generates a diverse yet auto/poly- and HIV-1-reactive antibody repertoire. Genes Immun 2012, 13:399-410.
19. Ippolito G.C., et al. Antibody repertoires in humanized NOD-scid-IL2Rgamma(null) mice and human B cells reveals human-like diversification and tolerance checkpoints in the mouse. PLoS ONE 2012, 7:pe35497.
20. Becker P.D., et al. Generation of human antigen-specific monoclonal IgM antibodies using vaccinated "human immune system" mice. PLoS ONE 2010, 5.
21. + cells. Exp Hematol 2003, 31:789-797.
22. Traggiai E., et al. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 2004, 304:104-107.
23. Ishikawa F., et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood 2005, 106:1565-1573.
24. -/- mice. J Virol 2007, 81:2700-2712.
25. Kuruvilla J.G., et al. Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice. Virology 2007, 369:143-152.
26. + B cells. Immunology 2011, 134:419-433.
27. Garcia S., Freitas A.A. Humanized mice: current states and perspectives. Immunol Lett 2012, 146:1-7.
28. Vuyyuru R., Patton J., Manser T. Human immune system mice: current potential and limitations for translational research on human antibody responses. Immunol Res 2011, 51:257-266.
29. Danner R., et al. Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells. PLoS ONE 2011, 6:e19826.
30. Lang J., et al. Studies of lymphocyte reconstitution in a humanized mouse model reveal a requirement of T cells for human B cell maturation. J Immunol 2013.
31. Strowig T., et al. Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. J Exp Med 2009, 206:1423-1434.
32. Kwant-Mitchell A., Ashkar A.A., Rosenthal K.L. Mucosal innate and adaptive immune responses against herpes simplex virus type 2 in a humanized mouse model. J Virol 2009, 83:10664-10676.
33. + cell depletion accelerates HIV-1 immunopathology in humanized mice. J Immunol 2010, 184:7082-7091.
34. Yajima M., et al. T cell-mediated control of Epstein-Barr virus infection in humanized mice. J Infect Dis 2009, 200:1611-1615.
35. Watanabe Y., et al. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice). Int Immunol 2009, 21:843-858.
36. -/- mice. Proc Natl Acad Sci U S A 2006, 103:15951-15956.
37. An D.S., et al. Use of a novel chimeric mouse model with a functionally active human immune system to study human immunodeficiency virus type 1 infection. Clin Vaccine Immunol: CVI 2007, 14:391-396.
38. Shultz L.D., et al. Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma(null) humanized mice. Proc Natl Acad Sci U S A 2010, 107:13022-13027.
39. Jaiswal S., et al. Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice. PLoS ONE 2009, 4:pe7251.
40. Brainard D.M., et al. Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice. J Virol 2009, 83:7305-7321.
41. Dudek T.E., et al. Rapid evolution of HIV-1 to functional CD8(+) T cell responses in humanized BLT mice. Sci Transl Med 2012, 4:143ra98.
42. Jaiswal S., et al. Enhanced humoral and HLA-A2-restricted dengue virus-specific T-cell responses in humanized BLT NSG mice. Immunology 2012, 136:334-343.
43. Cox J., et al. Mosquito bite delivery of dengue virus enhances immunogenicity and pathogenesis in humanized mice. J Virol 2012, 86:7637-7649.
44. Sato Y., Nagata S., Takiguchi M. Effective elicitation of human effector CD8(+) T cells in HLA-B*51:01 transgenic humanized mice after infection with HIV-1. PLoS ONE 2012, 7:pe42776.
45. Parsons C.H., et al. KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice. J Clin Invest 2006, 116:1963-1973.
46. Smith M.S., et al. Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model. Cell Host Microbe 2010, 8:284-291.
47. -/- mice after pharmacological immunosuppression. Am J Pathol 2010, 177:1311-1319.
48. Robinet E., Baumert T.F. A first step towards a mouse model for hepatitis C virus infection containing a human immune system. J Hepatol 2011, 55:718-720.
49. Firoz Mian M., et al. Humanized mice are susceptible to Salmonella typhi infection. Cell Mol Immunol 2011, 8:83-87.
50. Libby S.J., et al. Humanized nonobese diabetic-scid IL2rgamma null mice are susceptible to lethal Salmonella Typhi infection. Proc Natl Acad Sci U S A 2010, 107:15589-15594.
51. Arnold L., et al. Further improvements of the P. falciparum humanized mouse model. PLoS ONE 2011, 6:pe18045.
52. Wege A.K., et al. Leishmania major infection in humanized mice induces systemic infection and provokes a nonprotective human immune response. PLoS Neglect Trop Dis 2012, 6:pe1741.
53. Tonomura N., et al. Antigen-specific human T-cell responses and T cell-dependent production of human antibodies in a humanized mouse model. Blood 2008, 111:4293-4296.
54. Balazs A.B., et al. Antibody-based protection against HIV infection by vectored immunoprophylaxis. Nature 2012, 481:81-84.
55. + T cell levels in humanized mice. J Immunol 2013, 190:211-219.
56. Shultz L.D., et al. Humanized mice as a preclinical tool for infectious disease and biomedical research. Ann N Y Acad Sci 2011, 1245:50-54.
57. -/- mice improves engraftment of human hematopoietic cells in humanized mice. Proc Natl Acad Sci U S A 2011, 108:13218-13223.
58. Legrand N., et al. Functional CD47/signal regulatory protein alpha (SIRP(alpha)) interaction is required for optimal human T- and natural killer- (NK) cell homeostasis in vivo. Proc Natl Acad Sci U S A 2011, 108:13224-13229.
59. Willinger T., et al. Improving human hemato-lymphoid-system mice by cytokine knock-in gene replacement. Trends Immunol 2011, 32:321-327.